The findings indicate that TFPI-2 reduces the invasive and migratory capabilities of tumor cells by interacting with PSAP, offering a novel viewpoint and potential target for fibrosarcoma treatment [26] (Figure 6). This evidence concerns the gene TFPI2 and neoplasm.